Clinical Trial Update: Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Gallium-68 PSMA-11 PET imaging in patients with biochemical recurrence of prostate cancer; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Gallium-68 PSMA-11 PET (Gallium-68 PSMA-11)

Snippet

Sponsor: University of Michigan | Conditions: Prostate Cancer, Prostate Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-11-03